Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Didier Leturcq is active.

Publication


Featured researches published by Didier Leturcq.


Journal of Histochemistry and Cytochemistry | 1998

Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues

Michael R. D'Andrea; Didier Leturcq; Sherry M. Baker; Anders Brunmark; Ping Ling; Andrew L. Darrow; Rosemary J. Santulli; Lawrence F. Brass; Patricia Andrade–Gordon

PAR-2 is a second member of a novel family of G-protein-coupled receptors characterized by a proteolytic cleavage of the amino terminus, thus exposing a tethered peptide ligand that autoactivates the receptor. The physiological and/or pathological role(s) of PAR-2 are still unknown. This study provides tissue-specific cellular localization of PAR-2 in normal human tissues by immunohistochemical techniques. A polyclonal antibody, PAR-2C, was raised against a peptide corresponding to the amino terminal sequence SLIGKVDGTSHVTGKGV of human PAR-2. Significant PAR-2 immunoreactivity was detected in smooth muscle of vascular and nonvascular origin and stromal cells from a variety of tissues. PAR-2 was also present in endothelial and epithelial cells independent of tissue type. Strong immunolabeling was observed throughout the gastrointestinal tract, indicating a possible function for PAR-2 in this system. In the CNS, PAR-2 was localized to many astrocytes and neurons, suggesting involvement of PAR-2 in neuronal function. A role for PAR-2 in the skin was further supported by its immunolocalization in the epidermis. PAR-2C antibody exemplifies an important tool to address the physiological role(s) of PAR-2.


Journal of Clinical Investigation | 1992

Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.

Thomas R. Martin; John C. Mathison; Peter S. Tobias; Didier Leturcq; Ann M. Moriarty; R J Maunder; Richard J. Ulevitch

A plasma lipopolysaccharide (LPS)-binding protein (LBP) has been shown to regulate the response of rabbit peritoneal macrophages and human blood monocytes to endotoxin (LPS). We investigated whether LBP is present in lung fluids and the effects of LBP on the response of lung macrophages to LPS. Immunoreactive LBP was detectable in the lavage fluids of patients with the adult respiratory distress syndrome by immunoprecipitation followed by Western blotting, and also by specific immunoassay. In rabbits, the LBP appeared to originate outside of the lungs, inasmuch as mRNA transcripts for LBP were identified in total cellular RNA from liver, but not from lung homogenates or alveolar macrophages. Purified LBP enhanced the response of human and rabbit alveolar macrophages to both smooth form LPS (Escherichia coli O111B:4) and rough form LPS (Salmonella minnesota Re595). In the presence of LBP and LPS, the onset of tumor necrosis factor-alpha (TNF alpha) production occurred earlier and at an LPS threshold dose that was as much as 1,000-fold lower for both types of LPS. In rabbit alveolar macrophages treated with LBP and LPS, TNF alpha mRNA appeared earlier, reached higher levels, and had a prolonged half-life as compared with LPS treatment alone. Neither LPS nor LPS and LBP affected pHi or [Cai++] in alveolar macrophages. Specific monoclonal antibodies to CD14, a receptor that binds LPS/LBP complexes, inhibited TNF alpha production by human alveolar macrophages stimulated with LPS alone or with LPS/LBP complexes, indicating the importance of CD14 in mediating the effects of LPS on alveolar macrophages. Thus, immunoreactive LBP accumulates in lung lavage fluids in patients with lung injury and enhances LPS-stimulated TNF alpha gene expression in alveolar macrophages by a pathway that depends on the CD14 receptor. LBP may play an important role in augmenting TNF alpha expression by alveolar macrophages within the lungs.


Journal of Biological Chemistry | 1996

In Vivo Characterization of the Proteasome Regulator PA28

Kwangseog Ahn; Mark G. Erlander; Didier Leturcq; Per A. Peterson; Klaus Früh; Young Yang

A proteasome regulator, termed PA28, has been shown to modulate peptidase activities of the proteasomes in vitro. Two different but homologous PA28 molecules, designated as PA28α and PA28β, have been cloned. Both α and β polypeptides of PA28 are found in PA28 complexes isolated from cells, indicating that both are constituents of functional PA28 complexes. Using antisera specific to PA28α, PA28β, and epitope-tagged PA28 molecules, we show that expression of PA28α and PA28β is coordinately induced by various cytokines in different cell lines and that PA28 subunits and proteasomes have almost identical half-lives. In addition, we show that PA28 complexes are associated with 20 S but not 26 S proteasomes in vivo. Moreover, we demonstrate that PA28 complex is a heterohexamer composed of both α and β subunits with a stoichiometry of α3β3 in an alternating order.


Proceedings of the National Academy of Sciences of the United States of America | 1993

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14

J. Pugin; C C Schürer-Maly; Didier Leturcq; Ann M. Moriarty; Richard J. Ulevitch; Peter S. Tobias


Proceedings of the National Academy of Sciences of the United States of America | 1993

Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin

J D Lee; Vladimir V. Kravchenko; T N Kirkland; Jiahuai Han; Nigel Mackman; Ann M. Moriarty; Didier Leturcq; Peter S. Tobias; Richard J. Ulevitch


Proceedings of the National Academy of Sciences of the United States of America | 1999

Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: Implications for cellular iron homeostasis

Luisa Salter-Cid; Anders Brunmark; Yuanhao Li; Didier Leturcq; Per A. Peterson; Michael R. Jackson; Young Yang


Journal of Biological Chemistry | 1993

Analysis of lipopolysaccharide binding by CD14.

T N Kirkland; F Finley; Didier Leturcq; Ann M. Moriarty; J D Lee; Richard J. Ulevitch; Peter S. Tobias


American Journal of Physiology-lung Cellular and Molecular Physiology | 1996

Asthma and endotoxin : lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment

W. Dubin; Thomas R. Martin; P. Swoveland; Didier Leturcq; Ann M. Moriarty; Peter S. Tobias; E. R. Bleecker; S. E. Goldblum; J. D. Hasday


Archive | 1994

Methods and compositions for inhibiting cd14 mediated cell activation

Didier Leturcq; Ann M. Moriarty; Richard J. Ulevitch; Peter S. Tobias; John C. Mathison


American Journal of Physiology-lung Cellular and Molecular Physiology | 1997

Bronchoalveolar macrophage CD14 expression: shift between membrane-associated and soluble pools.

J. D. Hasday; W. Dubin; S. Mongovin; S. E. Goldblum; P. Swoveland; Didier Leturcq; Ann M. Moriarty; E. R. Bleecker; Thomas R. Martin

Collaboration


Dive into the Didier Leturcq's collaboration.

Top Co-Authors

Avatar

Ann M. Moriarty

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Peter S. Tobias

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John C. Mathison

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

T N Kirkland

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Anders Brunmark

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

J D Lee

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Per A. Peterson

Scripps Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge